United States · Who invested in Karuna Therapeutics?
Karuna Therapeutics's investors include ARCH Venture Partners, Fidelity, Alexandria Real Estate Equities, Wellcome Trust and SANDS, and 4 more on record. ARCH Venture Partners led its latest round.
United States · Series B startup
Who invested in Karuna Therapeutics
Funding summaryUpdated 26 Oct 2026
$68Mraised across 1 round since 2019, from 1 source
- Latest round
- Series B, $68MMar 2019
- Led by
- ARCH Venture Partners
- Investors
- 9 (1 led)
The rounds
- Mar 2019Series B$68M
ARCH Venture PartnersLead- Fidelity
Alexandria Real Estate Equities
Wellcome Trust
SANDS
Pivotal bioVenture Partners- Eventide
- PureTech
- Partner Fund
Reported by FinSMEs
Everyone who backed them
FidelityVC firm1round
EventideVC firm1round
PureTechGrowth equity1round
Partner Fundno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Karuna Therapeutics
How much has Karuna Therapeutics raised?
Karuna Therapeutics has raised $68M across 1 round since 2019.
When did Karuna Therapeutics last raise?
Karuna Therapeutics's most recent round was a Series B of $68M in Mar 2019, led by ARCH Venture Partners.
What was Karuna Therapeutics's biggest round?
Its most recent round, $68M in Mar 2019, is also its largest on record.
Who backed Karuna Therapeutics first?
Karuna Therapeutics's first round on record, in Mar 2019, was backed by ARCH Venture Partners, Fidelity and Alexandria Real Estate Equities and 6 others.
What stage is Karuna Therapeutics at?
Karuna Therapeutics's latest named round is a Series B, in Mar 2019.
Where is Karuna Therapeutics based?
Karuna Therapeutics is based in the United States.
Who led Karuna Therapeutics's rounds?
ARCH Venture Partners led the Series B in 2019.
Companies like Karuna Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.